Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chang-Ji-An Capsule in diarrhea-predominant IBS (liver-qi attacking spleen pattern)
CTR20223191Phase 2Completed
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Jan 2023
- Countries
- 1
01
Overview
A Phase 2 trial of Changji'an Capsule in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Started Jan 2023; status: completed.
02
Drugs
Changji'an Capsule
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on CTR20223191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223191.